Electrolyte abnormalities due to irinotecan administration in metastatic HER-2 positive breast cancer patients

J BUON. 2012 Oct-Dec;17(4):800.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Camptothecin / adverse effects
  • Camptothecin / analogs & derivatives*
  • Female
  • Humans
  • Hypocalcemia / chemically induced*
  • Hypokalemia / chemically induced*
  • Irinotecan
  • Middle Aged
  • Neoplasm Metastasis
  • Receptor, ErbB-2 / analysis*

Substances

  • Antineoplastic Agents, Phytogenic
  • Irinotecan
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Camptothecin